Blog

Pfizer puts Bamboo’s muscular dystrophy gene therapy to the test – FierceBiotech


FierceBiotech

Pfizer puts Bamboo's muscular dystrophy gene therapy to the test
FierceBiotech
At least two other trials of DMD gene therapies are also ongoing in the U.S., both involving candidates developed at Nationwide Children's Hospital (NCH) and partnered by Sarepta. One of the two phase 1/2 trials is based on delivery of a

and more »

2018-04-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.